Drug pricing
- The maximum retail price (MRP) of controlled-price medicines is fixed by the federal government on DRAP's recommendation and printed on the pack.
- The Drug Pricing Policy 2018 divides medicines into essential and non-essential, and sets rules for pricing new products and for annual inflation-linked (CPI) adjustments.
- In February 2024 the caretaker federal cabinet deregulated prices of medicines not on the National Essential Medicines List (SRO 228(I)/2024). Essential medicines remain price-controlled.
- DRAP later reported that prices rose for more than half of the deregulated medicines.
- Selling above the printed MRP is an offence.